The cost-effectiveness of different management strategies for patients on chronic warfarin therapy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
OBJECTIVE: To examine the cost-effectiveness of moving from usual care to more organized management strategies for patients on chronic warfarin therapy.
DESIGN: Using information available in the scientific literature, supplemented with data from a large health system and, when necessary, expert opinion, we constructed a 5-year Markov model to evaluate the health and economic outcomes associated with each of three different anticoagulation management approaches: usual care, anticoagulation clinic testing with a capillary monitor, and patient self-testing with a capillary monitor.
PATIENTS: Three hypothetical cohorts of patients beginning long-term warfarin therapy were used to generate model results.
MAIN RESULTS: Model results indicated that moving from usual care to anticoagulation clinic testing would result in a total of 1.7 thromboembolic events and 2.0 hemorrhagic events avoided per 100 patients over 5 years. Another 4.0 thromboembolic events and 0.8 hemorrhagic events would be avoided by moving to patient self-testing. When direct medical care costs and those incurred by patients and their caregivers in receiving care were considered, patient self-testing was the most cost-effective alternative, resulting in an overall cost saving.
CONCLUSIONS: Results illustrate the potential health and economic benefits of organized care management approaches and capillary monitors in the management of patients receiving warfarin therapy.
- Landefeld, CS, Beyth, RJ (1993) Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 95: pp. 315-28 CrossRef
- Matchar, DB, Samsa, GP, Cohen, SJ (1996) Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation. J Gen Intern Med 11: pp. 768-70 CrossRef
- Chiquette, E, Amato, MG, Bussey, HI (1995) Comparison of an anticoagulation clinic with routine medical care. Circulation 92: pp. 1-686
- Cortelazzo, S, Finazzi, G, Viero, P, Galli, M, Remuzzi, A, Parenzan, L (1993) Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 69: pp. 316-20
- White, RH, McKittrick, T, Takakuwa, J (1996) Management and prognosis of life-threatening bleeding during warfarin therapy. Arch Intern Med 156: pp. 1197-1201 CrossRef
- Ansell, JE, Patel, N, Ostrovsky, D, Nozzolillo, E, Peterson, AM, Fish, L (1995) Long-term patient self-management of oral anticoagulation. Arch Intern Med 155: pp. 2185-9 CrossRef
- Hasenkam, JM, Knudsen, L, Kimose, HH (1997) Practicability of patient self-testing or oral anticoagulant therapy by the international normalized ratio (INR) using a portable whole blood monitor. A pilot investigation. Thromb Res 85: pp. 77-82
- Bernardo A, Halhuber C. Long-term experience with patient self-management of oral anticoagulation. Ann Hematol. 1996;72:A62. Abstract.
- Anderson, DR, Harrison, L, Hirsh, J (1993) Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 153: pp. 1441-7 CrossRef
- Fihn, SD, McDonell, MB, Martin, DC (1993) Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med 118: pp. 511-20
- Fihn, SD, Callahan, CM, Martin, DC (1996) The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 124: pp. 970-9
- Gottlieb, LK, Salem-Schatz, S (1994) Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?. Arch Intern Med 154: pp. 1945-53 CrossRef
- The effect of low dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 323: pp. 1505-11 CrossRef
- Connolly, SJ, Laupacis, A, Gent, M, Roberts, RS, Cairns, JA, Joyner, C (1991) Canadian atrial fibrillation anticoagulation study. J Am Coll Cardiol 18: pp. 349-55 CrossRef
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342: pp. 1255-62
- Optimal oral anticoagulant therapy in patients with non-rheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 333: pp. 5-10 CrossRef
- Ezekowitz, MD, Bridgers, SL, James, KE (1992) Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. Veterans Affairs stroke prevention in nonrheumatic atrial fibrillation investigators. N Engl J Med 327: pp. 1406-12 CrossRef
- Petersen P, Godtfredsen J, Boysen G, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989;175–8.
- Stroke prevention in atrial fibrillation study. Circulation 84: pp. 527-39
- Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet 343: pp. 687-91
- Palaretti, G, Leal, N, Cocchen, S (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 348: pp. 423-8 CrossRef
- Meer, FJM, Rosendaal, FR, Vandenbroucke, JP, Briet, E (1993) Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 153: pp. 1557-62 CrossRef
- White, RH, McCurdy, SA, Mardensdorff, H, Woodruff, DE, Leftgoff, L (1989) Home prothrombin time monitoring after the initiation of warfarin therapy. Ann Intern Med 111: pp. 730-7
- Wilkinson, PR, Wolfe, CDA, Warburton, FG (1997) A long-term follow-up of stroke patients. Stroke 28: pp. 507-12
- Bonita, R, Solomon, N, Broad, JB (1997) Prevalence of stroke and strokerelated disability. Estimates from the Auckland Stroke Studies. Stroke 28: pp. 1898-1902
- Dorman, PJ, Waddell, F, Slattery, J, Dennis, M, Sandercock, P (1997) Is the EuroQol a valid measure of health-related quality of life after stroke?. Stroke 28: pp. 1876-82
- Tennant, A, Geddes, JML, Fear, J, Hillman, M, Chamberlain, MA (1997) Outcome following stroke. Disabil Rehabil 19: pp. 278-84
- Dighe, MS, Aparasu, RR, Rappaport, HM (1997) Factors predicting survival, changes in activity limitations, and disability in a geriatric post-stroke population. Gerontologist 37: pp. 483-9
- Naglie, G, Detsky, AS (1992) Treatment of chronic nonvalvular atrial fibrillation in the elderly: a decision analysis. Med Decis Making 12: pp. 239-49 CrossRef
- Disch, DL, Greenberg, ML, Holzberger, PT, Malenka, DJ, Birkmeyer, JD (1994) Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med 120: pp. 449-57
- Tsevat, J, Eckman, MH, McNutt, RA, Pauker, SG (1989) Warfarin for dilated cardiomyopathy: a bloody tough pill to swallow?. Med Decis Making 9: pp. 162-9 CrossRef
- Seto, TB, Taira, DA, Tsevat, J, Manning, WJ (1997) Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation. J Am Coll Cardiol 29: pp. 122-30 CrossRef
- Gage, BF, Cardinalli, AB, Albers, GW, Owens, DK (1995) Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 274: pp. 1839-45 CrossRef
- Sarent, R, Wainwright, E (1996) Crystal Ball Version 4.0 User Manual. CG Press, Broomfield, Colo
- Gold, MR, Siegel, JE, Russell, LB, Weinstein, MC (1996) Cost-effectiveness in Health and Medicine. Oxford University Press, Inc, New York, NY
- Ansell, JE, Hamke, AK, Holden, A, Knapic, N (1989) Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times. Am J Clin Pathol 91: pp. 587-9
- US Bureau of the Census, Current Population Reports, Money Income in the United States: 1996 (With Separate Data on Valuation of Noncash Benefits). Washington, DC: US Government Printing Office; 1997:60–197, Table 7.
- Murphy, DJ, Williamson, PS, Nease, DE (1994) Supportive family members of diabetic adults. Fam Pract Res J 14: pp. 323-31
- Mitchell, JB, Ballard, DJ, Whisnant, JP, Ammering, CJ, Samsa, GP, Matchar, DB (1996) What role do neurologists play in determining the costs and outcomes of stroke patients?. Stroke 27: pp. 1937-43
- Holloway, RG, Witter, DM, Lawton, KB, Lipscomb, J, Samsa, G (1996) Inpatient costs of specific cerebrovascular events at five academic medical centers. Neurology 46: pp. 860-860
- Health Insurance Association of America. Washington, DC: Source Book of Health Insurance Data, 1996. 854–60:1997.
- The cost-effectiveness of different management strategies for patients on chronic warfarin therapy
Journal of General Internal Medicine
Volume 15, Issue 1 , pp 31-37
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- anticoagulation management
- cost-effectiveness analysis
- decision analytic model
- Industry Sectors